Skip to main content
  • Sign in
  • Help
BOPA
  • Why join BOPA
  • Pricing
  • Education
    • BOPA Introduction to Cancer Course 2026
    • Courses and eLearning
    • SACT Verification Hub (Passport)
    • Resource Library
    • Cancer Hub
    • Education & Training Standards
    • Let’s Talk About SACT – a BOPA Podcast
  • About BOPA
    • About BOPA
    • Welcome to BOPA
    • Executive Committee
    • Subcommittees & working groups
    • Affiliated Groups
    • Cancer Advisory Groups & Specialist Interest Groups
    • International Groups
    • BOPA Fellows
    • Corporate Membership
    • BOPA membership FAQs
  • Conference
    • Latest Conference 2026
    • Past Symposiums / Conferences
  • News & Events
    • UKPPLB Open Letter
    • News
    • Events calendar
    • Submit event
  • Menu iconLCC
    • LCC
    • Cancer Hub
  • Menu iconBOPA/IOCN Monographs
  • Join BOPA
Join BOPA
BOPA Join BOPA
  • Why join BOPA
  • Pricing
  • Education
    • BOPA Introduction to Cancer Course 2026
    • Courses and eLearning
    • SACT Verification Hub (Passport)
    • Resource Library
    • Cancer Hub
    • Education & Training Standards
    • Let’s Talk About SACT – a BOPA Podcast
  • About BOPA
    • About BOPA
    • Welcome to BOPA
    • Executive Committee
    • Subcommittees & working groups
    • Affiliated Groups
    • Cancer Advisory Groups & Specialist Interest Groups
    • International Groups
    • BOPA Fellows
    • Corporate Membership
    • BOPA membership FAQs
  • Conference
    • Latest Conference 2026
    • Past Symposiums / Conferences
  • News & Events
    • UKPPLB Open Letter
    • News
    • Events calendar
    • Submit event
  • Menu iconLCC
    • LCC
    • Cancer Hub
  • Menu iconBOPA/IOCN Monographs
  • Join BOPA

Home » Community Pharmacy

Community Pharmacy

BOPA encourages its members to share helpful documents that can benefit other members.  BOPA respects the intellectual property of original authors and requires anyone who uses other members’ work to include an acknowledgment of, or reference to, the source in their version.

DISCLAIMER:
BOPA is not the author or owner of some of the documents published on our website.  BOPA as a professional interest group will share documents via its website that are of interest to BOPA members, but has no responsibility for use of the documents and for any recommendations within the documents so members must use these at their discretion. BOPA cannot accept responsibility for any errors or omissions or for any consequences from application of information in the documents attached and make no warranty, expressed or implicit with respect to the contents of this webpage. You must obtain professional or specialist advice before taking, or refraining from, any action on the basis of the content on our site or document(s) downloaded from it.

Posters and abstracts on the BOPA website remain the property of the authors and anyone wishing to reference or share this work must contact the authors directly. Abstracts subsequently published in JOPP follow copyright rules from JOPP.

Last reviewed: 18/03/21 by Melanie Dalby

Guidance on the oral anticancer medication (OAM) review service by community pharmacy

Guidelines, Report

View resources
Last reviewed: 18/03/21 by Sarah Glewis

Sharing the care – hospital and community pharmacy partnership for the management of glucocorticoid-induced diabetes (GID)

Abstracts

View resources
Last reviewed: 09/12/25 by BOPA Committee

BOPA Community Pharmacy Committee Terms of Reference V1.4 July 2018

ToR

View resources
Last reviewed: 10/07/19 by Fiona MacLean

Investigation of community pharmacists’ input to the pharmaceutical care of patients prescribed systemic anticancer therapy Results of a focus group and questionnaire.

Abstracts

View resources
Last reviewed: 10/07/19 by Melanie Dalby

Community Pharmacies Supporting Patients on Oral Anticancer Medications

Abstracts

View resources
Last reviewed: 10/07/19 by Melanie Dalby

User acceptability of a referral pathway to community pharmacy for patients on oral anticancer mediation

Abstracts

View resources
Last reviewed: 10/07/19 by Anne O’Connor

Understanding the Patient Preferences for Community Monitoring of Abiraterone: An analysis of new models involving community pharmacists.

Abstracts

View resources
Last reviewed: 17/03/21 by BOPA

BOPA Twitter Guide May 2019

Guidelines, Standard

View resources
Last reviewed: 10/07/19 by BOPA

BOPA Workforce Survey Poster August 2017

Guidelines, Standard

View resources

Filter for resources

  • Types

  • Tags

  • Reset

Previous 1 2
BOPA logo
  • Why join BOPA
  • Pricing/Join
  • Latest Conference 2026
  • Education
  • About
  • News & Events
  • Help
  • Go to LinkedIn
  • Go to Twitter
  • Go to Facebook
  • Go to Instagram
  • Go to Bluesky

© Copyright 2026 British Oncology Pharmacy Association.
Registered Charity No. 1065026

  • Privacy Policy
  • T&Cs Website
  • T&Cs Membership
  • Cookies
  • Contact
Designed and developed by Rouge
Our website uses cookies to distinguish you from other users of our website. This helps us to provide you with a good experience when you browse our website and also allows us to improve our site. By continuing to browse the site, you are agreeing to our use of cookies.